ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 253 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $19,800,000 | +65.1% | 705,608 | +100.0% | 0.15% | -12.1% |
| Q3 2021 | $11,992,000 | -58.4% | 352,804 | -50.0% | 0.17% | -7.0% |
| Q2 2021 | $28,832,000 | +103.0% | 705,608 | +100.0% | 0.19% | +3.9% |
| Q1 2021 | $14,204,000 | -73.5% | 352,804 | -61.0% | 0.18% | -68.6% |
| Q4 2020 | $53,504,000 | +32.6% | 904,854 | +9.0% | 0.57% | -2.5% |
| Q3 2020 | $40,363,000 | +73.8% | 830,000 | +72.9% | 0.59% | +56.6% |
| Q2 2020 | $23,222,000 | +73.0% | 480,000 | -3.0% | 0.38% | +7.4% |
| Q1 2020 | $13,424,000 | +47.1% | 495,000 | +62.3% | 0.35% | +93.4% |
| Q4 2019 | $9,126,000 | +0.1% | 305,000 | +3.4% | 0.18% | -26.4% |
| Q3 2019 | $9,116,000 | -33.8% | 295,000 | +3.5% | 0.25% | -22.2% |
| Q2 2019 | $13,766,000 | – | 285,000 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TIGER MANAGEMENT L.L.C. | 1,115,411 | $45,576,000 | 7.97% |
| Rappaport Reiches Capital Management, LLC | 133,330 | $5,447,864 | 5.73% |
| Matrix Capital Management Company, LP | 11,800,090 | $482,152,000 | 5.27% |
| Asymmetry Capital Management, L.P. | 168,172 | $6,872,000 | 4.72% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $1,225,543,000 | 3.72% |
| Eagle Health Investments LP | 257,827 | $10,535,000 | 3.61% |
| BERYLSON CAPITAL PARTNERS, LLC | 246,200 | $10,060,000 | 2.23% |
| Aristotle Atlantic Partners, LLC | 717,650 | $29,323,000 | 1.93% |
| DDD Partners, LLC | 250,382 | $10,231,000 | 1.55% |
| Casdin Capital, LLC | 1,440,000 | $58,838,000 | 1.49% |